Abstract: A delivery system for delivery of an implantable stented device to a body lumen that includes an elongated member having a distal tip and a proximal end portion, a wire connection member positioned between the distal tip and proximal end portion of the elongated member, and a plurality of capturing wires extending from a distal end of the wire connection member. Each of the capturing wires includes a distal end having a lower portion that is moveable relative to an upper portion between an open position and a closed position, and a slot defined by the upper and lower portions when they are in the closed position.
Abstract: A surgical method treats infections on a lead positioned at least partially within a patient's body. The surgical method includes uncoupling the lead from a pulse generator. The lead is then coupled to an ultrasound wave generator. Ultrasound waves are propagated from the ultrasound wave generator through the lead. Systems are disclosed.
Abstract: Some aspects relate to systems, devices, and methods of delivering rate responsive pacing therapy. The method includes monitoring activity information related to an activity level of a patient and delivering rate responsive pacing (RRP) to the patient at a pacing rate corresponding to a RRP profile. The RRP profile may be used to generate the pacing rate based on the activity information and may be adjusted based on the monitored activity information.
Abstract: A system and method of use thereof are disclosed, the system including a treatment source, such as an electrosurgical generator and a plurality of treatment devices operable to be coupled to the treatment source, one or more of the treatment devices being associated with one or more device identifiers which can be, for example, physically present on the device or contained in device software.
Type:
Grant
Filed:
December 20, 2017
Date of Patent:
July 25, 2023
Assignee:
Medtronic, Inc.
Inventors:
Robert Harrison, Kathryn Atwell, Michael Same, Aaron Kang-Lun Peng, Matthew Dawson, Gregory Pollieri
Abstract: A modular heart valve prosthesis includes a first heart valve device and a second heart valve device. The first heart valve device includes a first valve support including a first prosthetic valve disposed within the valve support, and an anchoring frame surrounding the first valve support and coupled to the first valve support. The first prosthetic valve includes synthetic fabric leaflets having a first thickness. The second heart valve device includes a second valve support including a second prosthetic valve disposed within the second valve support. The second prosthetic valve includes tissue leaflets having a second thickness, wherein the second thickness is greater than the first thickness. In a first configuration, the second heart valve device is separate from the first heart valve device, and in a second configuration, the second heart valve device is disposed within the first valve support of the first heart valve device.
Abstract: A method and system for determining a target location for a medical device having complex geometry relative to an anatomical feature, and for navigating and positioning the medical device at the target location. The system may include a medical device including a treatment element having a centroid, one or more navigation electrodes, and a longitudinal axis and a navigation system in communication with the one or more navigation electrodes, the navigation system including a processing unit. The processing unit may be programmed to define a plane that approximates a surface of the anatomical feature, define a centroid of the anatomical feature, define a vector that is normal to the plane and extends away from the centroid of the anatomical feature, and determine a target location for the treatment element of the medical device based on the vector to assist the user in placing the device for treatment.
Abstract: Systems, devices, and techniques are configured for analyzing evoked compound action potentials (ECAP) signals to assess the effect of a delivered electrical stimulation signal. In one example, a system includes processing circuitry configured to receive ECAP information representative of an ECAP signal sensed by sensing circuitry, and determine, based on the ECAP information, that the ECAP signal includes at least one of an N2 peak, P3 peak, or N3 peak. The processing circuitry may then control delivery of electrical stimulation based on at least one of the N2 peak, P3 peak, or N3 peak.
Type:
Grant
Filed:
August 23, 2021
Date of Patent:
July 25, 2023
Assignee:
Medtronic, Inc.
Inventors:
David A. Dinsmoor, Hank Bink, Kristin N. Hageman
Abstract: An implantable medical device includes a plurality of electrodes to detect electrical activity, a motion detector to detect mechanical activity, and a controller to determine at least one electromechanical interval based on at least one of electrical activity and mechanical activity. The activity detected may be in response to delivering a pacing pulse according to an atrioventricular (AV) pacing interval using the second electrode. The electromechanical interval may be used to adjust the AV pacing interval. The electromechanical interval may be used to determine whether cardiac therapy is acceptable or whether atrial or ventricular remodeling is successful.
Abstract: Devices, systems, and techniques are described to detect when a power transmitting and receiving system is in an inefficient position, which may cause a thermal response that less desirable than a more efficient position. The system may power transmitting device configured to wirelessly transfer electromagnetic energy to a power receiving device. Processing circuitry of the system may compute a target output power deliverable by the power transmitting device for a first duration and control the power transmitting device to output the target output power based in part on a heat limit. The processing circuitry may further calculate an energy transfer efficiency to the power receiving unit, update an adjustment factor based on the calculated energy transfer efficiency, and apply the adjustment factor to the heat limit for a subsequent duration.
Type:
Grant
Filed:
February 23, 2022
Date of Patent:
July 18, 2023
Assignee:
Medtronic, Inc.
Inventors:
Andrew Thomas Fried, Douglas W. Brown, Charles M. Nowell, Robert J. Monson, Venkat R. Gaddam, Brett Otteson
Abstract: An additive manufacturing system may include a heating cartridge defining an interior volume and at least one filament port. The system may include a heating element thermally coupled to the heating cartridge to heat the interior volume. The system may also include a filament handling system to feed at least one filament through the at least one filament port. The system may include a substrate handling system having at least a head stock. The system may include a controller configured to initiate or control movement of a substrate relative to the heating cartridge to apply a jacket to the substrate.
Abstract: The disclosure is directed to programming implantable stimulators to deliver stimulation energy via one or more implantable leads having complex electrode array geometries. The disclosure also contemplates guided programming to select electrode combinations and parameter values to support efficacy. The techniques may be applied to a programming interface associated with a clinician programmer, a patient programmer, or both. A user interface permits a user to view electrodes from different perspectives relative to the lead. For example, the user interface provides a side view of a lead and a cross-sectional view of the lead. The user interface may include an axial control medium to select and/or view electrodes at different axial positions along the length of a lead, and a rotational control medium to select and/or view electrodes at different angular positions around a circumference of the lead.
Type:
Grant
Filed:
May 22, 2020
Date of Patent:
July 18, 2023
Assignee:
Medtronic, Inc.
Inventors:
Steven M. Goetz, Richard T. Stone, Warren W. Ball, Carl D. Wahlstrand, Michael T. Hegland, Gabriela C. Molnar, James M. Olsen
Abstract: A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, the pulse train including at least 60 pulses, an inter-phase delay between 0 ?s and 5 ?s, an inter-pulse delay of at least 5 ?s, and a pulse width of 5 ?s.
Abstract: Medical device systems include processing circuitry configured to acquire sensed cardiac signals associated with cardiac activity of a heart of a patient, and to analyze the sensed cardiac signals to determine if a noise signal is present within the cardiac signals.
Abstract: An implantable medical device includes an electrically conductive first housing, a conductive feedthrough extending through the first housing, electronic circuitry positioned within the first housing, a device electrode, and a second housing. The electronic circuitry is electrically coupled to the first housing and the feedthrough, and senses electrical signals of a patient and/or delivers electrical stimulation therapy to the patient via the first housing and the feedthrough. The device electrode is configured to electrically connect with tissue and/or a fluid at a target site in the patient. A lead connector is configured to connect to a proximal end of an implantable medical lead. The lead connector includes a first connector contact electrically coupled to the feedthrough and a second connector contact electrically coupled to the first housing.
Type:
Grant
Filed:
September 22, 2020
Date of Patent:
July 11, 2023
Assignee:
Medtronic, Inc.
Inventors:
Andrew J. Ries, Wade M. Demmer, Troy E. Jackson
Abstract: Systems, methods, and devices are described herein for determining cardiac conduction system capture of ventricle from atrium (VfA) therapy. VfA therapy may be delivered at a plurality of different A-V delays while electrical activity of the patient is monitored. The electrical activity may then be utilized to determine whether the cardiac conduction system of the patient has been captured by the VfA therapy.
Abstract: A medical device is configured to deliver therapeutic electrical stimulation pulses by generating frequency modulated electrical stimulation pulse signals. The medical device includes a pulse signal source and a modulator. The pulse signal source generates an electrical stimulation pulse signal having a pulse width. The modulator may include a high frequency modulator configured to modulate a frequency of the pulse signal from a starting frequency down to a minimum frequency during the pulse width. The modulator may include a low frequency bias generator to modulate the offset of the pulse signal between a minimum offset and a maximum offset in other examples.
Type:
Grant
Filed:
February 15, 2021
Date of Patent:
July 11, 2023
Assignee:
Medtronic, Inc.
Inventors:
Vladimir P. Nikolski, Melissa G. T. Christie, Mark T. Marshall, Amy E. Thompson-Nauman
Abstract: Techniques are disclosed for using both feature delineation and machine learning to detect cardiac arrhythmia. A computing device receives cardiac electrogram data of a patient sensed by a medical device. The computing device obtains, via feature-based delineation of the cardiac electrogram data, a first classification of arrhythmia in the patient. The computing device applies a machine learning model to the received cardiac electrogram data to obtain a second classification of arrhythmia in the patient. As one example, the computing device uses the first and second classifications to determine whether an episode of arrhythmia has occurred in the patient. As another example, the computing device uses the second classification to verify the first classification of arrhythmia in the patient. The computing device outputs a report indicating that the episode of arrhythmia has occurred and one or more cardiac features that coincide with the episode of arrhythmia.
Type:
Grant
Filed:
July 12, 2021
Date of Patent:
July 11, 2023
Assignee:
Medtronic, Inc.
Inventors:
Niranjan Chakravarthy, Siddharth Dani, Tarek D. Haddad, Donald R. Musgrove, Andrew Radtke, Eduardo N. Warman, Rodolphe Katra, Lindsay A. Pedalty
Abstract: Systems and methods may use healthcare protocols for use with distributed ledger technology. The healthcare protocols may be used to, among other things, classify event data items as distributed ledger data items such that record of such classified event data items may be stored in a distributed ledger. Further, the healthcare protocols may be modified over time, and record of such modifications may also be stored in a distributed ledger.
Type:
Grant
Filed:
May 29, 2019
Date of Patent:
July 4, 2023
Assignee:
Medtronic, Inc.
Inventors:
Timothy D. Paffel, Michael D. Ryan, Jake Schutz, Tracy E. Kootsikas, Kurt R. Smith